Search clinical trials for: Placental growth factor

Total 41937 results

The Third Affiliated Hospital of Guangzhou Medical...

Recruiting

The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center

Preeclampsia | Maternal Deaths

China
Hospital Universitari Vall d'Hebron Research Institute

Not yet recruiting

Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler (earlyGRAFD)

Placenta Diseases | Fetal Growth Retardation | Preeclampsia

Spain
Chinese University of Hong Kong
National University Hospital, Singapore; The Affiliated Nanjing Drum Tower... and other collaborators

Recruiting

Labor Induction in Preeclampsia High-risk Women (FORECAST-IOL)

Pre-Eclampsia | Induction of Labor

Hong Kong, Thailand, Indonesia, Taiwan, Vietnam, Singapore, China
Assistance Publique - Hôpitaux de Paris

Recruiting

Vascular Biomarkers Predictive of the Progression From Gestational Hypertension to Preeclampsia in Pregnant Women (BIOVASC-PreHTA)

Pre-eclampsia | Gestational Hypertension

France
Meir Medical Center

Not yet recruiting

The Impact of Placental Factors on Fetal Intrauterine Growth and in Intrauterine Programming of the Metabolic Syndrome

Normal Pregnancies

Israel
Centre Hospitalier Universitaire de Saint Etienne

Completed

Impact of the sFlt-1/PlGF Ratio on Medical Decision-making and on Maternal and Neonatal Outcomes in Women Suspected of Preeclampsia

Preeclampsia Possible

France
Hospital Universitari Vall d'Hebron Research Institute

Completed

Management of Fetal Growth Restriction at Term: Angiogenic Factors Versus Feto-placental Doppler (GRAFD)

Fetal Growth Retardation

Spain
Centre Hospitalier Universitaire de Saint Etienne

Completed

IMPACT OF THE BIOLOGICAL RATIO ON MEDICAL DECISION MAKING IN WOMEN SUSPECTED OF PREECLAMPSIA

Pre-Eclampsia

France
Fundació Institut de Recerca de l'Hospital de la...
Carlos III Health Institute; Spanish Clinical Research Network - SCReN

Completed

Randomizated Open-label Control Trial to Evaluate if the Incorporation of sFlt1/PlGF Ratio in the Diagnosis and Classification of PE Improves Maternal and Perinatal Outcomes in Women With the Suspicion of the Disease (EuroPE)

Preeclampsia

Spain
Damascus University

Completed

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

Polycystic Ovary Syndrome | Infertility | In Vitro Fertilization | Intracytoplasmic Sperm Injection

Syrian Arab Republic
Damascus University

Completed

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.

Infertility | In Vitro Fertilization | Intracytoplasmic Sperm Injection

Syrian Arab Republic
Instituto Fernandes Figueira
Hospital de Clinicas de Porto Alegre; University of Campinas, Brazil; UPECLIN... and other collaborators

Completed

PREPARE, Prematurity Reduction by Pre-eclampsia Care (PREPARE)

Premature Birth | Pre-Eclampsia

Brazil
BioInvent International AB
Oxurion

Completed

Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours

Solid Tumors

Denmark
Fundació Institut de Recerca de l'Hospital de la...
Spanish Clinical Research Network - SCReN

Completed

First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction

Preeclampsia | Intrauterine Growth Restriction

Spain
Cengiz Gokcek Women's and Children's Hospital

Completed

sFlt- 1, PIGF, and Niacin Levels in Women With Premature Ovarian Insufficiency (POİ&niacin)

Premature Ovarian Insufficiency

Turkey
Johnbosco Ifunanya Nwafor

Completed

Placental Growth Factor as a Predictor of Adverse Pregnancy Outcomes in Preeclamptic Women

Pre-Eclampsia

Nigeria
Irish Centre for Fetal and Neonatal Translational...
University College Cork; National Maternity Hospital, Ireland; Coombe Women and... and other collaborators

Completed

Placental Growth Factor Assessment of Women With Suspected Pre-eclampsia (PARROT)

Pregnancy Complications | Pregnancy, High Risk | Pre-eclampsia

Ireland
CHU de Quebec-Universite Laval
Canadian Institutes of Health Research (CIHR); Laval University

Completed

First-trimester Prediction of Preeclampsia (PREDICTION)

Preterm Birth | Preeclampsia | Severe Preeclampsia | Fetal Growth Restriction

Canada
University of Pittsburgh

Terminated

Nutraceutical Citrulline in Pregnancy

Type 2 Diabetes

United States
Fetal Medicine Research Center, Spain

Unknown

Role of Placental Growth Factor (PlGF) in the Management of Non-Severe Preeclampsia (MAP)

Pregnancy; Pre-eclampsia, Mild

Spain
amera mohamed

Unknown

The Relationship Between Second Trimester Placental Growth Factor Level and Fetal Growth Restriction

Intra Uterine Growth Retardation

Egypt
John Uckele

Terminated

Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia

Preeclampsia

United States
Centre Hospitalier Universitaire de Saint Etienne
Groupe de Recherche sur la Thrombose

Completed

Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers (VOLUPLA)

Placenta Vascular Malformation

France
HaEmek Medical Center, Israel

Completed

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

Thromboembolism | Preeclampsia | Fetal Demise | Abruptio Placentae | Fetal Growth Restriction

Israel
Clinique Ovo

Terminated

Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21 (PlGF)

Pregnancy

Canada
Tel-Aviv Sourasky Medical Center

Unknown

Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity

Pregnancy Complications | Preeclampsia | Placental Abruption | Intrauterine Fetal Death | Intrauterine Fetal Growth Restriction

Israel
Dr R Viswa Chandra

Recruiting

Efficacy of Insulin Like Growth Factor-1(IGF-1) on Bone Regeneration in Intrabony Defects : A Clinico-radiograph Study

Intrabony Periodontal Defect

India
Peter MacCallum Cancer Centre, Australia
AbbVie

Not yet recruiting

MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma (EpLCART)

Relapsed/Refractory Large B-cell Lymphoma

Australia
Acepodia Biotech, Inc.

Not yet recruiting

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

Metastatic Solid Tumor | Locally Advanced Solid Tumor

United States
Hansoh BioMedical R&D Company

Not yet recruiting

A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer

Non-Squamous Non-Small Cell Lung Cancer
Zhangfa Song

Not yet recruiting

Chemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab

Metastatic Colorectal Cancer | MSS

China
AstraZeneca
Daiichi Sankyo

Not yet recruiting

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung15)

Metastatic Non-small Cell Lung Cancer
Kite, A Gilead Company
Arcellx, Inc.

Not yet recruiting

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma (iMMagine-3)

Multiple Myeloma
QED Therapeutics, Inc.

Recruiting

Prospective Clinical Assessment Study in Children With Hypochondroplasia (HCH)

Hypochondroplasia

United States, Australia, Norway, Portugal, Singapore, Spain
The First Affiliated Hospital of Soochow University

Not yet recruiting

Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

Multiple Myeloma | Newly Diagnosed | MRD | High Risk
M.D. Anderson Cancer Center

Not yet recruiting

Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)

Hormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular Carcinoma

United States
Maastricht University Medical Center
Gilead Sciences

Not yet recruiting

Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases

NSCLC Stage IV | Brain Metastases, Adult

Netherlands
Regeneron Pharmaceuticals

Not yet recruiting

An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting (SPECTRUM-US)

Visual Impairment | Diabetic Macular Edema (DME) | Neovascular Age-related Macular Degeneration (nAMD) | Wet Age-related Macular Degeneration (AMD)
Celgene
Bristol-Myers Squibb

Recruiting

A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation (KarMMa-9)

Multiple Myeloma

Austria, United States, Spain, Australia, Japan, France, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, Czechia, Denmark, Germany, Korea, Republic of, United Kingdom, Poland
National Cancer Institute (NCI)

Not yet recruiting

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Undifferentiated Carcinoma | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent Ovarian Undifferentiated Carcinoma and other conditions
Beijing Tiantan Hospital
Beijing University of Chemical Technology; Beijing Healthunion Cardio-Cerebrovascular...

Not yet recruiting

Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis (NATURAL)

Amyotrophic Lateral Sclerosis
Boston Immune Technologies and Therapeutics

Not yet recruiting

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

Peripheral T-cell Lymphoma | NHL | Cutaneous T Cell Lymphoma
Children's Hospital of Fudan University

Not yet recruiting

Thalidomide Therapy for VEOIBD

Inflammatory Bowel Diseases
Shanghai JMT-Bio Inc.

Not yet recruiting

JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations

Local Advanced or Metastatic NSCLC
Nanjing University School of Medicine

Recruiting

Daratumumab for Patients With Light Chain Amyloidosis

Light Chain (AL) Amyloidosis

China
AstraZeneca

Not yet recruiting

Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC (FOREFRONT)

Neoplasms | Respiratory Tract Diseases | Lung Diseases | Neoplasms by Site | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms

China
Puma Biotechnology, Inc.

Not yet recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer (ALISCA-Breast1)

Metastatic Breast Cancer | Recurrent Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer

United States
Nantes University Hospital
Janssen Pharmaceutica

Not yet recruiting

Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma (IFm2022-01)

Multiple Myeloma

France
Bayer

Recruiting

A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants

Healthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 Mutation

United States
AstraZeneca
Daiichi Sankyo

Not yet recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer (TROPION-Lung14)

Non-small Cell Lung Cancer

China, Taiwan, Korea, Republic of, Australia

Search clinical trials for: Placental growth factor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations